Trial Profile
Nesiritide as an Adjunctive Therapy for Children With Dilated Cardiomyopathy Admitted to the Intensive Care Unit.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Mar 2010
Price :
$35
*
At a glance
- Drugs Nesiritide (Primary)
- Indications Dilated cardiomyopathy
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 18 Mar 2010 New trial record